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NC-ND license (http://creativecommoBackground: Acute kidney injury (AKI) is common in critically ill premature infants. There is a
lack of consensus on the diagnostic definition of AKI in very low birth weight (VLBW) infants.
The primary aim of this study was to determine the incidence and risk factors for AKI in VLBW
infants using the AKI network (AKIN) and pRIFLE (pediatric Risk, Injury, Failure, Loss, End-
Stage) criteria and to evaluate whether Clinical Risk Index for Babies (CRIB II) score is a pre-
dictor of AKI. The secondary objective was to determine the extent of agreement between
the AKIN and pRIFLE criteria in the diagnosis of AKI in VLBW infants.
Methods: This was a retrospective chart review of 115 VLBW (< 1500 g) infants born in an ac-
ademic center with a Level 3B neonatal intensive care unit. Multiple congenital anomalies,
transfer to other centers, or death within the first 2 weeks were the exclusion criteria. Rele-
vant data were collected and analyzed in the first 2 weeks postnatally.
Results: AKI incidence, according to AKIN and pRIFLE criteria, was 20.1% and 22.6%, respec-
tively. As per the interrater reliability analysis, there was a fair agreement between the two
criteria (kappa Z 0.217). AKI was nonoliguric. The length of stay was significantly longer in
the AKI group. Prenatal nonsteroidal anti-inflammatory drug exposure, lower gestational
age, lower birth weight, respiratory distress syndrome, mechanical ventilation, patent ductus
arteriosus, hypotension, late onset sepsis, and higher CRIB II scores were significantly associ-
ated with AKI. Our regression analysis found CRIB II scores to be an independent risk factor
for AKI (odds ratio Z 1.621; 95% confidence interval, 1.230e2.167; p Z 0.001).
Conclusion: The determination of AKI using the pRIFLE and AKIN criteria yielded different re-
sults. pRIFLE appears to be more sensitive in VLBW infants. A high CRIB II score was recorded
for AKI. Future studies are necessary to develop a uniform definition and identify the risk fac-
tors to improve the outcomes in this population.
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+ MODEL1. Introduction
Acute kidney injury (AKI) has replaced acute renal failure as
a term used for the sudden decline in kidney function. AKI
has been shown to be an independent risk factor for
morbidity and mortality in neonates.1,2 However, there is a
lack of consensus as to which AKI diagnostic definition
should be used in very low birth weight (VLBW) infants. In
2004, the Acute Dialysis Quality Initiative group proposed
the RIFLE (Risk, Injury, Failure, Loss, End-Stage) criteria for
AKI diagnosis.3 These criteria have been modified to pedi-
atric RIFLE (pRIFLE) for use in children4 and the AKI network
(AKIN) criteria. The AKIN definition of AKI includes patients
who experience a 0.3-mg/dL increase in serum creatinine
within a 48-hour period.5 More recently, neonatal RIFLE
(nRIFLE) was proposed with a new cutoff value for oliguria
defined as UO < 1.5 mL/kg/h in neonates.6
The incidence and risk factors for neonatal AKI in VLBW
infants vary depending on the hospital and population stud-
ied.1,7 This may be attributable to the varied pattern of care
delivered at different neonatal intensive care units (NICUs)
and the differences in birth weight (BW) of preterm infants.
To overcome this and allow for comparison, several neonatal
illness severity scores have been developed to predict mor-
tality and morbidity in preterm infants. The Clinical Risk
Index for Babies (CRIB) II8 is a validated 5-item scoring system
used worldwide to determine the illness severity in addition
to predicting morbidity and mortality9,10 in preterm
infants < 32 weeks. CRIB II is determined within 1 hour, and
the 5-item components include BW, gestational age (GA),
body temperature, base excess, and the sex of the infant.
Scores range from 0 to 27 and are inversely related to out-
comes. Limiteddata exist on the incidenceand risk factors for
AKI in VLBW infants when compared to other patient pop-
ulations,11 and the utility of CRIB II scores as a predictor of AKI
in VLBW infants has not been extensively studied.
Despite multiple modifications for each unique popula-
tion, there is no unifying AKI diagnostic definition. Although
AKIN and pRIFLE have been compared in pediatric intensive
care unit patients,12 there have been no studies comparing
these criteria in VLBW infants. The primary aim of the study
was to determine the incidence and risk factors for AKI in
VLBW infants using the AKIN and pRIFLE criteria, and
evaluate whether CRIB II score is a predictor of AKI. The
secondary objective was to determine the extent of
agreement between the AKIN and pRIFLE criteria in the
diagnosis of AKI in VLBW infants.
2. Methods
2.1. Study population
We retrospectively reviewed all VLBW infants admitted to a
level 3B NICU of an academic center serving an inner city
population. All infants who were born between January
2012 and December 2013 and whose BW was  1500 g were
included in the study. Patients born with any major
congenital anomalies involving the kidneys were excluded.
We also excluded infants who died within the first few days
of life, those who had an insufficient number of serum
creatinine values prior to death or transfer to anotherPlease cite this article in press as: Daga A, et al., Diagnosis and Risk
Pediatrics and Neonatology (2016), http://dx.doi.org/10.1016/j.pedncenter as well, as periviable infants who were not resusci-
tated and provided with only comfort care. The Institu-
tional Review Board at the center approved the study
protocol and waived the need for consent.
2.2. Data collection
Data were collected from the electronic medical records of
all patients. The data included maternal and infant de-
mographics, GA, BW, APGAR (Appearance, Pulse, Grimace,
Activity, Respiration) scores, admission temperature and
base excess, medications, laboratory results, respiratory
support, and morbidities. Illness severity on admission was
assessed using the updated CRIB II score.8 AKI was classified
using all three definitions: pRIFLE, AKIN, and nRIFLE (Table
1). For each definition, the creatinine criterion and/or
urine output criterion was used. An AKI diagnosis was made
only after the first 48 hours of life, which avoided calling
the expected low urine output during the first 2 days of life
of an infant as AKI. Additionally, because neonatal serum
creatinine may reflect maternal creatinine in the first
2 days of life, serum creatinine measurements were
recorded only after the first 48 hours of life. For patients
with multiple episodes of AKI, the highest stage reached for
any episode was used for the analysis. Serum creatinine was
measured using an alkaline picrate (Jaffe) method trace-
able to isotope dilution mass spectrometry. As the pRIFLE
criterion uses the estimated glomerular filtration rate
(eGFR) in its definition (Table 1), we used the modified
Schwartz and Work13 method to best calculate the eGFR,
which has been used in prior studies for pediatric patients
aged between 0 years and 18 years.4,14e16
2.3. Definitions
Respiratory distress syndrome was defined as respiratory
distress accompanied by hypoxemia, FiO2 requirement >
35%, and ground glass appearance on chest X-ray. Small for
gestational age was defined as BW < 10th percentile for the
GA. Presumed early-onset clinical sepsis was defined as the
onset of signs of sepsis within the first 72 hours of life
without a positive blood or cerebrospinal fluid culture and
receipt of antibiotics for at least 5 days.17 Late-onset sepsis
was defined as occurring after 72 hours of life.18
2.4. Statistical analysis
All statistical analyses were performed using SPSS version
21 (SPSS Inc., Chicago, IL, USA). Medians for continuous
variables were compared using with ManneWhitney U test
because the assumptions of normality could not always
be satisfied. Proportions for categorical variables were
compared using Pearson’s Chi-square or Fisher’s exact tests
as appropriate. Continuous variables with normal distribu-
tion were compared using means and Student t test. Odds
ratios and 95% confidence intervals were calculated to
determine the odds of developing AKI among infants with
or without it. Because of the high possibility of multi-
collinearity, forward stepwise binary logistic regression was
performed to determine the variables that were considered
to be independent risk factors for AKI within the first 2 weeksFactors of Acute Kidney Injury in Very Low Birth Weight Infants,
eo.2016.08.002
Table 1 Staged diagnostic criteria for AKI.
AKIN pRifle nRifle
Stage Serum creatinine Urine output Class eGFR Urine output Class eGFR Urine output
1 Increased by >0.3
mg/dL or increased
by 150e200%
<0.5 mL/kg/
h  6 h
Risk Decreased
by 25%
<0.5 mL/kg/
h  6 h
Risk Decreased
by 25%
<1.5 mL/kg/
h  24 h
Injury Decreased
by 50%
<0.5 mL/kg/
h  12 h
Injury Decreased
by 50%
<1.0 mL/kg/
h  24 h
2 Increased by
>200e300%
<0.5 mL/kg/
h  12 h
Failure Decreased
by 75%
<0.3 mL/kg/
h  24 h
or anuria  12 h
Failure Decreased
by 75%
<0.7 mL/kg/
h  24 h or
anuria  12 h3 Increased by >300%
or >4.0 mg/dL with
acute rise of
0.5 mg/dL
<0.3 mL/kg/
h  24 h
or anuria  12 h
Loss Failure >4 wk Loss Failure >4 wk
ESRD Failure >3 mo ESRD Failure >3mo
AKI Z acute kidney injury; AKIN Z Acute Kidney Injury Network; eGFR Z estimated GFR; ESRD Z end-stage renal disease;
nRIFLE Z neonatal RIFLE (Risk, Injury, Failure, Loss, End-Stage); pRIFLE Z pediatric RIFLE.
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with the development of AKI in univariate analysis. A two-
sided significance level of 0.05 was set for all tests.
3. Results
A total of 165 patients (weighing < 1500 g) were admitted
to the NICU during the study period. Forty-two infants died
within the first 4 days of life. Most of these infants were
periviable and were only provided comfort, whereas the
remainder had an insufficient number of serum creatinine
measurements for the diagnosis of or otherwise of AKI. Other
exclusions involved eight infants transferred to outside hos-
pitals within the first 8 days of life. Thus, a total of 115 pa-
tients were included in the final AKI analysis (see Figure 1).
3.1. Demographics/patient characteristics
The median maternal age was 26.0 years [interquartile
range (IQR), 22.0e31.0]. The median GA and BW were
29.0 weeks (IQR, 27.0e30.0) and 1100 g (IQR, 790e1330),
respectively. Fifty-six percent of the population was male,
and 64% (74/115) of the population was African American.
Hispanics accounted for 22% (25/115), Caucasians 4.3% (5/
115), and others 9.6% (11/115).
3.2. AKI incidence
Twenty-four patients (20.1%) developed AKI using the AKIN
criteria. Twenty-six patients (22.6%) developed AKI using
the pRIFLE criteria. All patients who had AKI based on the
AKIN criteria also had the same diagnosis using the pRIFLE
criteria. Two infants with AKI based on the pRIFLE criteria
had changes only in eGFR over a 1-week period. None of the
patients included in this study had the F, L, and E stages of
pRIFLE or stage 3 of the AKIN criteria. Sixty-two percent of
the patients who were diagnosed to have AKI using the AKIN
criteria had their first episode in the 1st week of life. As per
the interrater reliability analysis, there was a fair agree-
ment between these two criteria (kappa Z 0.217). All in-
fants diagnosed with AKI were nonoliguric (UO > 1.5 mL/
kg/h). The incidence rate of AKI using nRIFLE definition was
22.6%, which is exactly the same rate as that diagnosed byPlease cite this article in press as: Daga A, et al., Diagnosis and Risk
Pediatrics and Neonatology (2016), http://dx.doi.org/10.1016/j.pednpRIFLE, because both of these definitions entail the same
eGFR criteria for AKI diagnosis (Table 1). None of the pa-
tients met nRIFLE’s new oliguria criteria (UO < 1.5 mL/kg/
h) as proposed by Bezerra et al.63.3. Risk factors
Maternal, perinatal, and infant factors were compared
between infants, with and without AKI (diagnosed by AKIN
criteria). Out of the maternal factors listed in Table 2,
prenatal NSAID (nonsteroidal anti-inflammatory drug)
exposure and cesarean delivery were significantly higher in
patients who developed AKI. Greater illness severity as
assessed using the CRIB II score was significantly higher in
the AKI group as compared to the non-AKI group (13.5 vs. 7,
p <0.001). Additionally, infants with AKI were more likely
to be of lower GA, have lower BW, be intubated at birth,
and become mechanically ventilated in addition to being
exposed to prenatal NSAIDs. Furthermore, infants who
developed AKI were more likely to have respiratory distress
syndrome, have a patent ductus arteriosus, require vaso-
pressor support for hypotension, as well as develop late-
onset sepsis. Maternal hypertensive disorders, exposure to
prenatal steroids, chorioamnionitis, and maternal sub-
stance abuse were similar between the AKI and non-AKI
groups (p > 0.05). Among the infant factors (Table 3),
APGAR scores, umbilical artery catheterization, early-onset
sepsis, and intraventricular hemorrhage were similar be-
tween the AKI and non-AKI groups.
Variables included in the forward stepwise binary logis-
tic regression analysis with an entry and removal proba-
bility cutoff of 0.05 and 0.1, respectively, were GA, BW,
CRIB II score, late onset sepsis, 5-minute APGAR score,
hemodynamically significant PDA, vasopressor support,
intubation at birth, and mechanical ventilation. CRIB II
score was the strongest and the only independent predictor
of AKI in this cohort of VLBW infants (odds ratio Z 1.621;
95% confidence interval, 1.230e2.167; p Z 0.001).
Mortality analysis was not performed because none of
the patients included in this study died within the first
2 weeks of life. However, length of stay was noted to be
significantly higher in patients with AKI (68 days vs. 34 days;
p Z 0.02).Factors of Acute Kidney Injury in Very Low Birth Weight Infants,
eo.2016.08.002
Figure 1 Patient flow and eligibility diagram. * Median (interquartile range).
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This primary aim of this study was to determine the inci-
dence and risk factors for AKI in VLBW infants using the
AKIN and pRIFLE criteria, and evaluate whether CRIB II
score is a predictor of AKI. The secondary objective was to
determine the extent of agreement between the AKIN and
pRIFLE criteria in the diagnosis of AKI in VLBW infants. We
found that AKI was associated with lower GA, lower BW,
higher CRIB II scores, need for mechanical ventilation,
vasopressor support for hypotension, hemodynamicallyTable 2 Comparison of maternal and perinatal characteristics
Variables All patients
(N Z 115)
n (%)
Chorioamnionitis 36 (32)
Prolonged rupture of membranes 36 (32)
Prenatal NSAID exposure 20 (18)
Prenatal steroids 95 (86)
Maternal substance abuse 22 (20)
Pregnancy-induced hypertension/preeclampsia 32 (28)
Clinically identifiable intrapartum event* 43 (41)
Cesarean delivery 68 (61)
AKI Z acute kidney injury; CI Z confidential interval; NSAID Z nons
* Includes placenta previa, placental abruption, cord prolapse, ute
Please cite this article in press as: Daga A, et al., Diagnosis and Risk
Pediatrics and Neonatology (2016), http://dx.doi.org/10.1016/j.pednsignificant PDA requiring medical, or surgical treatment
along with late-onset sepsis. These risk factors suggest that
the lightest, more premature, and sickest VLBW infants
within the cohort developed AKI. Our study found that a
higher CRIB II score on admission is an independent and
strong predictor of AKI in VLBW infants. In this population of
preterm VLBW infants, the components of the CRIB II scores
that are modifiable include body temperature and base
excess. Thus, the association between higher CRIB II scores
and AKI19 and other unfavorable outcomes10 could poten-
tially be ameliorated using proper and effective neonatalof infants with and without acute kidney injury.
AKI OR (95% CI)
Yes (N Z 24)
n (%)
No (N Z 91)
n (%)
8 (33) 28 (31) 1.089 (0.417e2.843)
6 (25) 30 (35) 0.611 (0.219e1.704 0)
8 (33) 12 (14) 3.083 (1.084e8.768)
20 (83) 75 (87) 0.733 (0.211e2.550)
4 (17) 18 (20) 0.778 (0.236e2.562)
7 (29) 25 (27) 1.071 (0.396e2.892)
12 (55) 31 (37) 2.052 (0.794e5.300)
20 (87) 48 (55) 5.556 (1.539e20.061)
teroidal anti-inflammatory drug; OR Z odds ratio.
rine rupture.
Factors of Acute Kidney Injury in Very Low Birth Weight Infants,
eo.2016.08.002
Table 3 Comparison of the characteristics and clinical course of infants with and without acute kidney injury.
Variables All patients (N Z 115)
n (%)* or
median (IQR)
AKI OR (95% CI) or p
Yes (N Z 24)
n (%)* or
median (IQR)
No (N Z 91)
n (%)* or
median (IQR)
Gestational age (wk) 29 (27e30) 25 (24e27) 29 (27e30) <0.001
Birth weight (g) 1100 (790e1330) 700 (605e960) 1170 (920e1380) <0.001
CRIB II score 7.0 (5.0e11.0) 13.5 (8.0e15.0) 7.0 (4.0e9.0) <0.001
APGAR scores (1 min) 5 (3e7) 5 (3e6) 5 (3e7) 0.34
APGAR scores (5 min) 8 (6e9) 7 (6e8) 8 (7e9) 0.046
SGA 12 (10) 4 (17) 8 (9) 2.132 (0.581e7.822)
Positive pressure ventilation at birth 94 (83) 22 (92) 72 (80) 2.750 (0.591e12.788)
Intubation 69 (61) 19 (79) 50 (56) 2.964 (1.016e8.645)
Mechanical ventilation 66 (59) 21 (88) 45 (51) 6.689 (1.860e24.055)
Respiratory distress syndrome 88 (77) 23 (96) 65 (71) 9.200 (1.181e71.688)
Patent ductus arteriosus 43 (37) 14 (58) 29 (32) 2.945 (1.169e7.420)
Patent ductus arteriosus treatmenty 23 (20) 9 (38) 14 (16) 2.443 (0.670e8.901)
Vasopressor support 20 (18) 8 (33) 12 (13) 3.250 (1.144e9.231)
Early onset sepsis 80 (75) 21 (88) 59 (68) 3.201 (0.880e11.667)
Late onset sepsis 44 (38) 19 (79) 25 (27) 12.540 (3.883e40.499)
Umbilical artery catheter 81 (71) 17 (71) 64 (71) 0.99 (0.366e2.655)
Intraventricular hemorrhage 25 (22) 5 (21) 20 (22) 0.984 (0.310e2.815)
Length of stay (d), m  s 44  25 68  14 34  19 0.02
APGAR Z Appearance, Pulse, Grimace, Activity, Respiration; CI Z Confidence interval; CRIB Z Clinical Risk Index for Babies;
IQR Z interquartile range; OR Z odds ratio; SGA Z small for gestational age.
* Percentages rounded off to the nearest whole number.
y Includes treatment with indomethacin or ibuprofen.
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immediate postdelivery period. Our results are consistent
with the recent studies by Weintraub et al19 and Carmody
et al20 in VLBW infants.
The results of our study reveal that one in five VLBW
infants developed AKI within the first 2 weeks. This is
similar to the rate of 18% reported by Koralkar et al1 but
substantially lower than the 30e40% reported in other
studies.19,20 This can be explained by the wide variation in
the AKI diagnostic definitions. Although there was no mor-
tality data in this study, AKI was associated with increased
length of stay, as reported previously. Our study also shows
that most neonatal AKI were mild and classified as either
stage 1 of AKIN or R and I stages of pRIFLE.
We found that the incidence rates of AKI based on the
pRIFLE and AKIN definitions were different, and this is similar
to the findings of two other studies,15,21 which compared
pRIFLE and AKIN among pediatric inpatients. They found
pRIFLE to bemore sensitive because it identifiedmore stage 1
AKI events. In this study, pRIFLE identifiedmore patients with
AKI because of the changes in eGFR over a 1-week period and
was found to be more sensitive in diagnosing AKI. Going for-
ward, it would be interesting to determine whether one cri-
terion is superior to the other based on the differences in
outcomes seen with AKI being diagnosed with one criterion
versus the other. However, given the small sample size of this
study and the lack of long-term follow-up of these patients,
we were unable to study this difference in outcomes. Each
definition has its advantages. AKIN definition does not require
the measurement of the infant’s length or eGFR calculation,
whereas pRIFLE does. Meanwhile, pRIFLE tracks creatinine
changes over a 1-week period as opposed to 48 hours as perPlease cite this article in press as: Daga A, et al., Diagnosis and Risk
Pediatrics and Neonatology (2016), http://dx.doi.org/10.1016/j.pednthe AKIN criteria. Because of the differences in the incidence
ofAKI reportedbasedondifferentdefinitionsappliedand lack
of uniformity, it is difficult to compare studies from an
epidemiological standpoint. This highlights the need to adopt
a single and universal diagnostic definition in VLBW infants,
which has the capability to predict both short-to-mediumand
long-term outcomes such as bronchopulmonary dysplasia,
retinopathy of prematurity, and chronic kidney disease.
Our study evaluated the urine output of each patient.
However, none of the patients who developed AKI had oli-
guria. This result is consistent with the fact that AKI in
newborns is generally nonoliguric.22 However, a recent study
concluded that a higher cutoff for oliguria (UO< 1.5 mL/Kg/
24 h) was associated with higher mortality, mechanical
ventilation duration, and the length of hospital stay.6 Thus, a
new urine output criterion (UO < 1.5 mL/kg/24 h) was
incorporated into pRIFLE, which was later referred to as
neonatal RIFLE23 (see Table 1). Our study also evaluated AKI
based on nRIFLE’s urine output criteria and found that none
of the patients met this proposed criterion.
Recent studies have largely focused on specific subgroups
such as neonates with congenital diaphragmatic hernia24 or
congenital heart disease,25 thereby making it difficult to
determine the risk for thebroaderpopulationofVLBWinfants.
Our study has several limitations. First, because of the
retrospective nature of the study and its reliance on
already existing serum creatinine values, we were unable
to assess the potential confounders in the diagnosis of AKI.
VLBW infants have unique and distinct physiologies, making
the interpretation of serum creatinine and the measure-
ment of urine output difficult. Serum creatinine may also
reflect maternal values and fluctuate during the 1st week ofFactors of Acute Kidney Injury in Very Low Birth Weight Infants,
eo.2016.08.002
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crease until 25e50% of the kidney function has been lost.26
Second, newer AKI definitions such as Kidney Diseases
Improving Global Outcomes24 and Neonatal AKI criteria26
were not evaluated in this study. Third, our laboratory
uses an alkaline picrate (Jaffe) method to measure creati-
nine. This technique is subject to interference from albu-
min, immunoglobulins, unconjugated bilirubin, and
hemoglobins (both A and F),25 and it may overestimate
serum creatinine by 0.2 mg/dL in VLBW infants.27 Fourth,
we did not look into novel biomarkers, which have been
shown to predict AKI in this population.28
In summary, in this single-center retrospective review of
VLBW infants, AKI was common (20e22%). AKI was more
likely in those who had a CRIB II score of > 10. AKI in VLBW
infants was nonoliguric and associated with a longer length
of stay. AKIN and pRIFLE diagnostic definitions resulted in
different AKI incidence in our study. Thus, our findings
support the need for a uniform AKI diagnostic definition
tailored for unique, challenging, and developmentally
immature VLBW infant populations. Further prospective
studies are needed to develop a better AKI diagnostic tool
that includes novel biomarkers in conjunction with serum
creatinine and urine output.Conflicts of interest
The authors declare no conflict of interest.References
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